Sinergium Biotech is leading the new project to develop mRNA vaccines for avian influenza (H5N1)

Sinergium Biotech is leading the new project to develop mRNA vaccines for avian influenza (H5N1)

Daily Current Affairs   /   Sinergium Biotech is leading the new project to develop mRNA vaccines for avian influenza (H5N1)

Change Language English Hindi

Category : Science and Tech Published on: August 02 2024

Share on facebook
  • Sinergium Biotech, supported by WHO and MPP, is leading an initiative to develop mRNA vaccines for avian influenza (H5N1), aiming to enhance pandemic preparedness in low- and middle-income 
  • The project will focus on preclinical development and intends to share technology and expertise worldwide, promoting equitable access and fostering international collaboration.
Recent Post's

  • Ravi Jain, Business Head of Krutrim AI, has resigned after the company unveiled new AI products.

    Read More....

  • The Union Cabinet approved a 3% hike in dearness allowance for central government employees and dearness relief for pensioners.

    Read More....

  • Union Minister Jyotiraditya Scindia inaugurated the International 6G Symposium, highlighting the potential of 6G in driving economic growth.

    Read More....

  • UGRO Capital partnered with US International Development Finance Corporation to enhance financial inclusion in India's MSME sector.

    Read More....

2024 © and Powered By Graposs Edutech Private Limited

Terms & Condition Privacy Policy Disclaimer